These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3897613)

  • 1. [Fundamental and clinical studies of a sustained release preparation of cefaclor in the surgical field].
    Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Ito T; Tanabe M; Fukuhara A; Sakakibara O
    Jpn J Antibiot; 1985 Mar; 38(3):859-68. PubMed ID: 3897613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of S6472 (prolonged action preparation of cefaclor) in the treatment of skin and soft tissue infections. A double blind comparison of S6472 and cefaclor].
    Sakai K; Fujimoto M; Ueda T; Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Doi S
    Jpn J Antibiot; 1985 Oct; 38(10):2716-34. PubMed ID: 3908726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fundamental and clinical studies on S6472 (a new prolonged acting preparation of cefaclor) in the urological field].
    Kamidono S; Fujii A; Harada M; Arakawa S; Umezu K; Kataoka N; Ishigami J; Hirooka K; Shimatani N; Matsushita M
    Jpn J Antibiot; 1985 Mar; 38(3):869-904. PubMed ID: 3928939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
    Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
    Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological and clinical studies on the long acting cefaclor (S6472)].
    Fujimoto M; Sakai K; Ueda T; Doi S; Sasaki T; Morimoto Y; Sawada A; Masada A
    Jpn J Antibiot; 1985 Mar; 38(3):849-57. PubMed ID: 3897612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolonged action preparation of cefaclor].
    Sakamoto T; Kawai S; Doi Y; Aita K; Sonoyama T; Nishimura K; Matsuda S; Ito M; Imagawa T; Yasuda M
    Jpn J Antibiot; 1985 Mar; 38(3):813-21. PubMed ID: 3897611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fundamental and clinical studies of cefaclor in oral surgery].
    Morihana K; Sakamoto H; Gotoh J; Konnai T; Uematsu M; Toyoura T; Sasaki J; Ohno K; Yoshida H; Hasegawa M
    Jpn J Antibiot; 1984 Jun; 37(6):1006-22. PubMed ID: 6387212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
    Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
    Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of sustained release preparations of cefaclor in dental infections. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor].
    Horii M; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Inaba O; Takada S; Kimura J
    Jpn J Antibiot; 1985 Apr; 38(4):1117-40. PubMed ID: 3897614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A double-blind comparative study on the efficacy of S6472, cefaclor, in the treatment of bacterial bronchitis].
    Oshima S; Yokoyama Y; Kikuiri T; Murakami T; Nishihara H; Shimizu T; Abe M; Kurihara Y; Itoh C; Takeuchi K
    Jpn J Antibiot; 1986 Oct; 39(10):2726-53. PubMed ID: 3543432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
    Hiraga Y; Omichi M; Sasaoka S
    Jpn J Antibiot; 1988 Sep; 41(9):1304-8. PubMed ID: 3241328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase I clinical studies of S6472 (sustained release preparations of cefaclor)].
    Ohtomo M; Ito M; Iida M; Yasuda M; Sonoyama T; Matsuda S
    Jpn J Antibiot; 1985 Mar; 38(3):822-33. PubMed ID: 4032714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies of S6472 in otorhinolaryngologic infections].
    Baba S; Kinoshita H; Mori Y; Suzuki K; Ohyama M; Katsuta K; Furuta S; Ohno I; Noboru T; Yamamoto M
    Jpn J Antibiot; 1985 Jul; 38(7):1750-60. PubMed ID: 4068219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of S 6472 granule preparation (sustained-release cefaclor) in chronic respiratory airway infections].
    Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Numata H; Takahashi K; Yamaki I; Ishii S
    Jpn J Antibiot; 1988 Sep; 41(9):1325-33. PubMed ID: 3241332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
    Tanimoto H; Nakamori Y
    Jpn J Antibiot; 1988 Sep; 41(9):1319-24. PubMed ID: 3241331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical study on S6472, sustained release preparation of cefaclor, dermatological area].
    Kawanami T; Shibata A; Hanawa S; Morishima T
    Jpn J Antibiot; 1990 Sep; 43(9):1621-8. PubMed ID: 2262967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fundamental and clinical studies of S 6472 (sustained release preparation of cefaclor) in the pediatric field].
    Sugita M; Toyonaga Y; Nakamura H; Kurosu Y; Hori M
    Jpn J Antibiot; 1985 Sep; 38(9):2444-52. PubMed ID: 3908736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A double blind comparative study on the efficacy of S6472, cefaclor and amoxicillin, in the treatment of bacterial pneumonia].
    Shibaki H; Chimoto T; Nakabayashi T; Ishii Y; Tosaka M; Watanabe H; Onodera S; Shimizu T; Sasaki N; Ikeda Y
    Jpn J Antibiot; 1986 Mar; 39(3):853-86. PubMed ID: 3525883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical examination of S 6472 (sustained release preparations of cefaclor on chronic respiratory tract infection].
    Hayashi I; Ohnuma K
    Jpn J Antibiot; 1988 Sep; 41(9):1313-8. PubMed ID: 3241330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Absorption and excretion studies of S6472 (sustained release preparations of cefaclor)].
    Tateno M; Ito M; Iida M; Yasuda M; Sonoyama T; Matsuda S
    Jpn J Antibiot; 1985 Mar; 38(3):834-48. PubMed ID: 4032715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.